Bicycle Therapeutics plc (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

3.620

-0.040 (-1.09%)

At close: Nov 2, 2026, 4:00 PM EST

3.600

-0.020 (-0.55%)

After-hours: Nov 2, 2026, 7:30 PM EST

Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	469.93	628.11	879.52	526.42	339.15	438.68
Cash & Short-Term Investments	469.93	628.11	879.52	526.42	339.15	438.68
Cash Growth	-27.52%	-28.59%	67.07%	55.22%	-22.69%	222.58%
Accounts Receivable	-	-	-	-	2.05	1
Other Receivables	52.36	35.59	35.65	24.04	19.16	10.91
Receivables	52.36	35.59	35.65	24.04	21.21	11.91
Prepaid Expenses	15.27	19.18	13.43	11.41	9.02	7.97
Total Current Assets	537.56	682.89	928.61	561.87	369.38	458.56
Property, Plant & Equipment	17.65	21.91	17.19	27.68	32.77	17.79
Other Long-Term Assets	11.98	12.81	11.07	5.79	8.46	3.45
Total Assets	567.18	717.6	956.87	595.34	410.61	479.79

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	9.59	9.67	15.79	13.05	6.47	2.72
Accrued Expenses	32.97	41.46	35.45	26.38	21.86	11.29
Current Portion of Leases	1.32	2.76	5.5	4.88	3.13	2.38
Current Unearned Revenue	-	2.96	10.19	24.98	20.42	19.27
Other Current Liabilities	0.59	0.14	0.3	0.26	1.47	0.57
Total Current Liabilities	44.46	56.98	67.23	69.54	53.34	36.24
Long-Term Debt	-	-	-	30.7	30.32	29.87
Long-Term Leases	12.86	14.1	3.99	9.38	10.89	12.08
Long-Term Unearned Revenue	3.69	35.51	91.47	110.22	41.46	52.07
Other Long-Term Liabilities	0.89	1.03	1.12	4.58	3.83	3.28
Total Liabilities	61.9	107.62	163.81	224.41	139.83	133.54

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.9	0.89	0.89	0.55	0.39	0.38
Additional Paid-In Capital	1,531	1,512	1,473	883.45	601.11	567.64
Retained Earnings	-1,021	-899.75	-680.79	-511.76	-331.1	-218.38
Comprehensive Income & Other	-5.34	-3.51	0.12	-1.3	0.39	-3.39
Total Common Equity	505.28	609.98	793.06	370.93	270.78	346.25
Shareholders' Equity	505.28	609.98	793.06	370.93	270.78	346.25
Total Liabilities & Equity	567.18	717.6	956.87	595.34	410.61	479.79

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	14.18	16.85	9.49	44.96	44.33	44.34
Net Cash (Debt)	455.74	611.26	870.03	481.47	294.83	394.34
Net Cash Growth	-29.08%	-29.74%	80.70%	63.30%	-25.24%	228.03%
Net Cash Per Share	6.54	8.82	14.95	13.53	9.94	15.73
Filing Date Shares Outstanding	70.09	69.71	69.2	42.59	30.02	29.6
Total Common Shares Outstanding	69.99	69.37	69.06	42.43	29.87	29.58
Working Capital	493.1	625.9	861.38	492.33	316.04	422.32
Book Value Per Share	7.22	8.79	11.48	8.74	9.06	11.71
Tangible Book Value	505.28	609.98	793.06	370.93	270.78	346.25
Tangible Book Value Per Share	7.22	8.79	11.48	8.74	9.06	11.71
Machinery	19.62	19.06	16.53	16.91	16.24	7.11
Leasehold Improvements	12.48	12.03	10.9	11	10.74	0.81

SEC Filings: 10-K · 10-Q